skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Center for Cancer Research
CCR Home | About CCR | CCR Intranet

Tissue Array Research Program (TARP)

Tissue by X coordinate


Number Sample # Block Code X Coordinate Y Coordinate Tumor Type Sex Age Other Information
501 1 marker core 0 0 Liver      
451 1 normal tissue 1 1 adrenal     XX-00-21B
456 6 normal tissue 1 2 breast     XX-00-35
461 11 normal tissue 1 3 cerebellum     XX-00-17-1A
466 16 normal tissue 1 4 esophagus     XX-00-24E
471 21 normal tissue 1 5 liver     L
476 26 normal tissue 1 7 lymph node      
481 31 normal tissue 1 8 ovary      
486 36 normal tissue 1 9 prostate      
491 41 normal tissue 1 10 small bowel      
496 46 normal tissue 1 11 testis      
26 1 YY-00-0055 1 14 Breast Adenocarcinoma F 79 ductal
31 6 YY-00-0069 1 15 Breast Adenocarcinoma F 76 ductal
36 11 YY-00-0180 1 16 Breast Adenocarcinoma F 27 ductal
41 16 YY-00-0192 1 17 Breast Adenocarcinoma F 53 ductal
46 21 YY-00-0209 1 18 Breast Adenocarcinoma F 35 ductal, IPOX ER positive, PR negative
51 26 YY-00-0219 1 20 Breast Adenocarcinoma F 70 lobular
56 31 YY-00-0349 1 21 Breast Adenocarcinoma F U ductal
61 36 YY-00-0355 1 22 Breast Adenocarcinoma F U lobular with signet rings
66 41 YY-01-0005 1 23 Breast Adenocarcinoma F 36 ductal, met to LN, ER and PR+, c-erb-B2 3+
71 46 YY-01-0014 1 24 Breast Adenocarcinoma F 61 met to LN, ER, PR and c-erbB2 negative
76 51 YY-01-0069 1 26 Breast Adenocarcinoma F 78 ductal and DCIS
81 56 YY-01-0144 1 27 Breast Adenocarcinoma F U lobular
86 61 YY-01-0152 1 28 Breast Adenocarcinoma F U ductal
91 66 YY-01-0158 1 29 Breast Adenocarcinoma F U ductal
96 71 YY-01-0166 1 30 Breast Adenocarcinoma F U ductal, S/P surg and XRT
452 2 normal tissue 2 1 adrenal    
457 7 normal tissue 2 2 breast      
462 12 normal tissue 2 3 cerebrum, gray matter     XX-00-17-2A
467 17 normal tissue 2 4 esophagus    
472 22 normal tissue 2 5 liver      
477 27 normal tissue 2 7 lymph node      
482 32 normal tissue 2 8 ovary      
487 37 normal tissue 2 9 prostate      
492 42 normal tissue 2 10 small bowel      
497 47 normal tissue 2 11 thyroid      
27 2 YY-00-0056 2 14 Breast Adenocarcinoma F 49 lobular with signet ring features
32 7 YY-00-0175 2 15 Breast Adenocarcinoma F 40 ductal
37 12 YY-00-0181 2 16 Breast Adenocarcinoma F 35 ductal
42 17 YY-00-0193 2 17 Breast Adenocarcinoma F 68 ductal
47 22 YY-00-0210 2 18 Breast Adenocarcinoma F 59 ductal
52 27 YY-00-0332 2 20 Breast Adenocarcinoma F U poorly differentiated
57 32 YY-00-0351 2 21 Breast Adenocarcinoma F U ductal
62 37 YY-00-0356 2 22 Breast Adenocarcinoma F U ductal
67 42 YY-01-0006 2 23 Breast Adenocarcinoma F 51 ductal, ER and PR negative, c-erb-B2 3+
72 47 YY-01-0015 2 24 Breast Adenocarcinoma F 66 ductal
77 52 YY-01-0073 2 26 Breast Adenocarcinoma F 63 ductal, ER-, PR+, c-erb-B2 -
82 57 YY-01-0145 2 27 Breast Adenocarcinoma F U lobular
87 62 YY-01-0153 2 28 Breast Adenocarcinoma F U ductal and DCIS
92 67 YY-01-0160 2 29 Breast Adenocarcinoma F U ductal
97 72 YY-01-0167 2 30 Breast Adenocarcinoma F U ductal, ER-, PR-, c-erb-B2 -, tumor 3.1 cm
453 3 normal tissue 3 1 bladder     XX-00-19A
458 8 normal tissue 3 2 breast      
463 13 normal tissue 3 3 cerebrum, white matter     XX-00-17-3A
468 18 normal tissue 3 4 heart     XX-00-25A
473 23 normal tissue 3 5 lung     XX-00-7
478 28 normal tissue 3 7 mesothelium      
483 33 normal tissue 3 8 pancreas     XX-00-23-B
488 38 normal tissue 3 9 salivary gland     XX-00-34-B
493 43 normal tissue 3 10 spleen      
498 48 normal tissue 3 11 tongue      
28 3 YY-00-0063 3 14 Breast Adenocarcinoma F 48 ductal
33 8 YY-00-0177 3 15 Breast Adenocarcinoma F 37 ductal
38 13 YY-00-0186 3 16 Breast Adenocarcinoma F 45 ductal
43 18 YY-00-0196 3 17 Breast Adenocarcinoma F 48 ductal
48 23 YY-00-0211 3 18 Breast Adenocarcinoma F 56 ductal
53 28 YY-00-0337 3 20 Breast Adenocarcinoma F 75 ductal IPOX positive ER (15%), negative PR, c-erb-B2
58 33 YY-00-0352 3 21 Breast Adenocarcinoma F U ductal
63 38 YY-00-0359 3 22 Breast Adenocarcinoma F 67 ductal
68 43 YY-01-0009 3 23 Breast Adenocarcinoma F 56 ductal, met to LN
73 48 YY-01-0064 3 24 Breast Adenocarcinoma F 61 ductal, IPOX: ER +, PR, c-erbB-2 -
78 53 YY-01-0074 3 26 Breast Adenocarcinoma F 59 ductal
83 58 YY-01-0146 3 27 Breast Adenocarcinoma F U poorly differentiate
88 63 YY-01-0154 3 28 Breast Adenocarcinoma F U ductal, ER+, PR and c-erbB-2 -
93 68 YY-01-0162 3 29 Breast Adenocarcinoma F U ductal, ER+, PR+, DCIS, tumor 1.8cm
98 73 YY-01-0169 3 30 Breast Adenocarcinoma F U ductal with DCIS, tumor 1.9 cm
454 4 normal tissue 4 1 bladder      
459 9 normal tissue 4 2 breast      
464 14 normal tissue 4 3 colon     XX-00-10B
469 19 normal tissue 4 4 kidney, cortex     XX-00-9A
474 24 normal tissue 4 5 lung      
479 29 normal tissue 4 7 mesothelium      
484 34 normal tissue 4 8 peripheral nerve      
489 39 normal tissue 4 9 skin      
494 44 normal tissue 4 10 spleen      
499 49 normal tissue 4 11 uterus, endometrium     XX-00-11-C
29 4 YY-00-0064 4 14 Breast Adenocarcinoma F 60 ductal
34 9 YY-00-0178 4 15 Breast Adenocarcinoma F 34 ductal
39 14 YY-00-0188 4 16 Breast Adenocarcinoma F 69 ductal, IPOX ER, PR negative
44 19 YY-00-0197 4 17 Breast Adenocarcinoma F 48 lobular
49 24 YY-00-0212 4 18 Breast Adenocarcinoma F 71 ductal
54 29 YY-00-0343 4 20 Breast Adenocarcinoma F U ductal
59 34 YY-00-0353 4 21 Breast Adenocarcinoma F U ductal
64 39 YY-00-0468 4 22 Breast Adenocarcinoma F 60 ductal
69 44 YY-01-0011 4 23 Breast Adenocarcinoma F 74 ductal, ER and PR +, cerb-B2 2+
74 49 YY-01-0065 4 24 Breast Adenocarcinoma F 50 ductal
79 54 YY-01-0076 4 26 Breast Adenocarcinoma F 79 ductal
84 59 YY-01-0147 4 27 Breast Adenocarcinoma F U ductal
89 64 YY-01-0155 4 28 Breast Adenocarcinoma F U ductal, ER, PR +, c-erb-B2 -
94 69 YY-01-0163 4 29 Breast Adenocarcinoma F U ductal, ER-, PR-, DICS, tumor >5 cm
99 74 YY-01-0170 4 30 Breast Adenocarcinoma F U ductal, ER+, PR+, c-erb-B2-, focal DCIS, tumor 2.9 cm
455 5 normal tissue 5 1 bone marrow     XX-00-33A
460 10 normal tissue 5 2 breast      
465 15 normal tissue 5 3 colon      
470 20 normal tissue 5 4 kidney, medulla      
475 25 normal tissue 5 5 lung      
480 30 normal tissue 5 7 muscle      
485 35 normal tissue 5 8 placenta, membranes      
490 40 normal tissue 5 9 skin      
495 45 normal tissue 5 10 stomach      
500 50 normal tissue 5 11 uterus, myometrium     XX-00-11-C
30 5 YY-00-0066 5 14 Breast Adenocarcinoma F 62 poorly differentiated
35 10 YY-00-0179 5 15 Breast Adenocarcinoma F 37 DCIS only
40 15 YY-00-0189 5 16 Breast Adenocarcinoma F 70 ductal
45 20 YY-00-0199 5 17 Breast Adenocarcinoma F 62 ductal
50 25 YY-00-0218 5 18 Breast Adenocarcinoma F 57 ductal IPOX positive for ER, PR (focal)
55 30 YY-00-0346 5 20 Breast Adenocarcinoma F U ductal
60 35 YY-00-0354 5 21 Breast Adenocarcinoma F U lobular with signet rings
65 40 YY-01-0002 5 22 Breast Adenocarcinoma F 73 ductal, ER and PR +, c-erb-B2 3+
70 45 YY-01-0013 5 23 Breast Adenocarcinoma F 52 ductal, ER, PR and c-erb-B2 negative
75 50 YY-01-0066 5 24 Breast Adenocarcinoma F 81 Lobular, ER, PR +
80 55 YY-01-0078 5 26 Breast Adenocarcinoma F 79 Hx prior Chemo Tx, Er-, PR-
85 60 YY-01-0151 5 27 Breast Adenocarcinoma F U ductal and DCIS
90 65 YY-01-0156 5 28 Breast Adenocarcinoma F U ductal, ER, PR+, c-erb-B2 -
95 70 YY-01-0165 5 29 Breast Adenocarcinoma F U lobular, tumor ~0.5 cm
100 75 YY-01-0171 5 30 Breast Adenocarcinoma F U lobular, ER+, PR+, c-erb_b2, tumor 4.0 cm
101 1 YY-00-0029 7 14 Colonic Adenocarcinoma F 49 Tubular Adenoma only
106 6 YY-00-0041 7 15 Colonic Adenocarcinoma M 67  
111 11 YY-00-0225 7 16 Colonic Adenocarcinoma F 77  
116 16 YY-00-0230 7 17 Colonic Adenocarcinoma M 90  
121 21 YY-00-0235 7 18 Colonic Adenocarcinoma M 73  
126 26 YY-00-0240 7 20 Colonic Adenocarcinoma F 58  
131 31 YY-00-0247 7 21 Colonic Adenocarcinoma F 76  
136 36 YY-00-0261 7 22 Colonic Adenocarcinoma M U  
141 41 YY-00-0283 7 23 Colonic Adenocarcinoma M 68  
146 46 YY-01-0020 7 24 Colonic Adenocarcinoma F 73  
151 51 YY-01-0082 7 26 Colonic Adenocarcinoma F 58  
156 56 YY-01-0128 7 27 Colonic Adenocarcinoma U U  
161 61 YY-01-0133 7 28 Colonic Adenocarcinoma U U  
166 66 YY-01-0200 7 29 Colonic Adenocarcinoma U U  
171 71 YY-01-0227 7 30 Colonic Adenocarcinoma U U mucinous, with signet rings
1 1 YY-00-0540 8 1 Brain Tumor U U GBM
6 6 YY-00-0545 8 2 Brain Tumor U U GBM
11 11 YY-00-0550 8 3 Brain Tumor U U GBM
16 16 YY-00-0556 8 4 Brain Tumor U U GBM
21 21 YY-00-0561 8 5 Brain Tumor U U GBM
301 1 YY-00-0022 8 7 Melanoma F 22 IPOX positive for s100, HMB-45
306 6 YY-00-0096 8 8 Melanoma U U  
311 11 YY-00-0503 8 9 Melanoma M 49
316 16 YY-01-0043 8 10 Melanoma M 50  
321 21 YY-01-0184 8 11 Melanoma U U metastatic
102 2 YY-00-0031 8 14 Colonic Adenocarcinoma F 90  
107 7 YY-00-0220 8 15 Colonic Adenocarcinoma U U Tubular Adenoma only
112 12 YY-00-0226 8 16 Colonic Adenocarcinoma F 86  
117 17 YY-00-0231 8 17 Colonic Adenocarcinoma M 72  
122 22 YY-00-0236 8 18 Colonic Adenocarcinoma F 88  
127 27 YY-00-0241 8 20 Colonic Adenocarcinoma F 55  
132 32 YY-00-0248 8 21 Colonic Adenocarcinoma F 72  
137 37 YY-00-0266 8 22 Colonic Adenocarcinoma F 44  
142 42 YY-00-0497 8 23 Colonic Adenocarcinoma M 49  
147 47 YY-01-0021 8 24 Colonic Adenocarcinoma F 54  
152 52 YY-01-0083 8 26 Colonic Adenocarcinoma M 54  
157 57 YY-01-0129 8 27 Colonic Adenocarcinoma U U mucinous
162 62 YY-01-0134 8 28 Colonic Adenocarcinoma U U mucinous, with signet rings
167 67 YY-01-0201 8 29 Colonic Adenocarcinoma U U  
172 72 YY-01-0229 8 30 Colonic Adenocarcinoma M 80
2 2 YY-00-0541 9 1 Brain Tumor U U GBM
7 7 YY-00-0546 9 2 Brain Tumor U U GBM
12 12 YY-00-0551 9 3 Brain Tumor U U GBM
17 17 YY-00-0557 9 4 Brain Tumor U U GBM
22 22 YY-00-0562 9 5 Brain Tumor U U GBM
302 2 YY-00-0023 9 7 Melanoma F 82  
307 7 YY-00-0100 9 8 Melanoma F 78 IPOX positive for HMB45, negative for S100
312 12 YY-00-0505 9 9 Melanoma M 60  
317 17 YY-01-0101 9 10 Melanoma U U  
322 22 YY-01-0185 9 11 Melanoma U U metastatic
103 3 YY-00-0032 9 14 Colonic Adenocarcinoma F 76  
108 8 YY-00-0221 9 15 Colonic Adenocarcinoma U U  
113 13 YY-00-0227 9 16 Colonic Adenocarcinoma F 41  
118 18 YY-00-0232 9 17 Colonic Adenocarcinoma F 45  
123 23 YY-00-0237 9 18 Colonic Adenocarcinoma M 71  
128 28 YY-00-0242 9 20 Colonic Adenocarcinoma F 78  
133 33 YY-00-0249 9 21 Colonic Adenocarcinoma M 38  
138 38 YY-00-0268 9 22 Colonic Adenocarcinoma M 56  
143 43 YY-01-0016 9 23 Colonic Adenocarcinoma M 61  
148 48 YY-01-0022 9 24 Colonic Adenocarcinoma F 78 mucinous
153 53 YY-01-0085 9 26 Colonic Adenocarcinoma M 46 mucinous
158 58 YY-01-0130 9 27 Colonic Adenocarcinoma U U  
163 63 YY-01-0197 9 28 Colonic Adenocarcinoma U U  
168 68 YY-01-0203 9 29 Colonic Adenocarcinoma U U  
173 73 YY-01-0230 9 30 Colonic Adenocarcinoma M 77
3 3 YY-00-0542 10 1 Brain Tumor U U GBM
8 8 YY-00-0547 10 2 Brain Tumor U U GBM
13 13 YY-00-0552 10 3 Brain Tumor U U GBM
18 18 YY-00-0558 10 4 Brain Tumor U U GBM
23 23 YY-00-0563 10 5 Brain Tumor U U GBM
303 3 YY-00-0025 10 7 Melanoma M 41 IPOX positive S100, melin (sp?)
308 8 YY-00-0101 10 8 Melanoma M 83 IPOX positive for S100, HMB45, negative for cytokeratin (unspecified), CD3, CD20, CD30
313 13 YY-00-0506 10 9 Melanoma F 71  
318 18 YY-01-0102 10 10 Melanoma U U  
323 23 YY-01-0186 10 11 Melanoma U U metastatic
104 4 YY-00-0033 10 14 Colonic Adenocarcinoma M 87  
109 9 YY-00-0222 10 15 Colonic Adenocarcinoma M 39  
114 14 YY-00-0228 10 16 Colonic Adenocarcinoma M 54  
119 19 YY-00-0233 10 17 Colonic Adenocarcinoma F 76 liver metastasis
124 24 YY-00-0238 10 18 Colonic Adenocarcinoma M 72  
129 29 YY-00-0245 10 20 Colonic Adenocarcinoma F 83  
134 34 YY-00-0251 10 21 Colonic Adenocarcinoma F 71  
139 39 YY-00-0273 10 22 Colonic Adenocarcinoma M 64  
144 44 YY-01-0017 10 23 Colonic Adenocarcinoma M 53  
149 49 YY-01-0023 10 24 Colonic Adenocarcinoma F 76  
154 54 YY-01-0126 10 26 Colonic Adenocarcinoma F 61  
159 59 YY-01-0131 10 27 Colonic Adenocarcinoma U U  
164 64 YY-01-0198 10 28 Colonic Adenocarcinoma U U  
169 69 YY-01-0204 10 29 Colonic Adenocarcinoma U U  
174 74 YY-01-0231 10 30 Colonic Adenocarcinoma M 81
4 4 YY-00-0543 11 1 Brain Tumor U U GBM
9 9 YY-00-0548 11 2 Brain Tumor U U GBM
14 14 YY-00-0554 11 3 Brain Tumor U U GBM
19 19 YY-00-0559 11 4 Brain Tumor U U GBM
24 24 YY-00-0564 11 5 Brain Tumor U U GBM
304 4 YY-00-0094 11 7 Melanoma M 50  
309 9 YY-00-0258 11 8 Melanoma M 43  
314 14 YY-00-0507 11 9 Melanoma F 51  
319 19 YY-01-0103 11 10 Melanoma U U Pos HMB45, S100, Vimentin; Neg LCA, keratin
324 24 YY-01-0222 11 11 Melanoma U U metastatic
105 5 YY-00-0034 11 14 Colonic Adenocarcinoma F 67  
110 10 YY-00-0223 11 15 Colonic Adenocarcinoma M 37  
115 15 YY-00-0229 11 16 Colonic Adenocarcinoma M 51  
120 20 YY-00-0234 11 17 Colonic Adenocarcinoma M 81  
125 25 YY-00-0239 11 18 Colonic Adenocarcinoma F 61  
130 30 YY-00-0246 11 20 Colonic Adenocarcinoma M 52  
135 35 YY-00-0252 11 21 Colonic Adenocarcinoma F 69  
140 40 YY-00-0277 11 22 Colonic Adenocarcinoma F 51  
145 45 YY-01-0018 11 23 Colonic Adenocarcinoma M 70  
150 50 YY-01-0081 11 24 Colonic Adenocarcinoma F 65  
155 55 YY-01-0127 11 26 Colonic Adenocarcinoma F 54  
160 60 YY-01-0132 11 27 Colonic Adenocarcinoma U U  
165 65 YY-01-0199 11 28 Colonic Adenocarcinoma U U mucinous with signet rings
170 70 YY-01-0205 11 29 Colonic Adenocarcinoma U U  
175 75 YY-01-0232 11 30 Colonic Adenocarcinoma F 66 mucinous
5 5 YY-00-0544 12 1 Brain Tumor U U GBM
10 10 YY-00-0549 12 2 Brain Tumor U U GBM
15 15 YY-00-0555 12 3 Brain Tumor U U GBM
20 20 YY-00-0560 12 4 Brain Tumor U U GBM
25 25 YY-01-0113 12 5 Brain Tumor U U GBM
305 5 YY-00-0095 12 7 Melanoma F 73 IPOX positive for S100, HMB45, vimentin, negative for Cytokeratin (unspecified) & CD45
310 10 YY-00-0502 12 8 Melanoma F 73  
315 15 YY-01-0041 12 9 Melanoma M 35  
320 20 YY-01-0104 12 10 Melanoma F 39  
325 25 YY-01-0241 12 11 Melanoma M 82 metastatic to lymph node, extensive necrosis
176 1 YY-00-0071 13 14 Lung Cancer F 74  
181 6 YY-00-0078 13 15 Lung Cancer F 84  
186 11 YY-00-0092 13 16 Lung Cancer F 50  
191 16 YY-00-0146 13 17 Lung Cancer F 80  
196 21 YY-00-0153 13 18 Lung Cancer M 51  
201 26 YY-00-0160 13 20 Lung Cancer F 71  
206 31 YY-00-0168 13 21 Lung Cancer M 54  
211 36 YY-00-0309 13 22 Lung Cancer F 56  
216 41 YY-00-0328 13 23 Lung Cancer M 73  
221 46 YY-00-0532 13 24 Lung Cancer F 76  
226 51 YY-01-0028 13 26 Lung Cancer M 66 squamous
231 56 YY-01-0090 13 27 Lung Cancer M 68 squamous
236 61 YY-01-0096 13 28 Lung Cancer M 72 squamous
241 66 YY-01-0141 13 29 Lung Cancer U U poorly differentiate
246 71 YY-01-0180 13 30 Lung Cancer U U squamous
251 1 YY-00-0011 14 1 Lymphoma M 14 IPOX: L-26 positive
256 6 YY-00-0016 14 2 Lymphoma F 69 Hodgkins Lyphoma IPOX: R-S cells positive Ki-1, Leu-M1
261 11 YY-00-0045 14 3 Lymphoma M 46 IPOX positive for CD20, CD45R, negative CDw75, CD3, CD43, CD45RO
266 16 YY-00-0125 14 4 Lymphoma F 79 Spleen, Flow Kappa restricted, B-cell lineage
271 21 YY-00-0132 14 5 Lymphoma F 37 IPOX positive for CD20, CD79a, CD45, negative for S100, cytokertatin, CD15, CD3
276 26 YY-00-0295 14 7 Lymphoma F 34 spleen, IPOX Positive for CD20, CD19, negative for CD5, CD23, CD10
281 31 YY-00-0301 14 8 Lymphoma M 53  
286 36 YY-00-0510 14 9 Lymphoma M 11 Hodgkins Lymphoma
291 41 YY-01-0055 14 10 Lymphoma M 56 spleen, B- cell,CD20 positive
296 46 YY-01-0105 14 11 Lymphoma M U  
177 2 YY-00-0072 14 14 Lung Cancer M 63  
182 7 YY-00-0080 14 15 Lung Cancer M 67  
187 12 YY-00-0139 14 16 Lung Cancer M 75  
192 17 YY-00-0149 14 17 Lung Cancer M 61  
197 22 YY-00-0155 14 18 Lung Cancer M 50  
202 27 YY-00-0161 14 20 Lung Cancer M 65  
207 32 YY-00-0170 14 21 Lung Cancer F 59  
212 37 YY-00-0312 14 22 Lung Cancer F 66  
217 42 YY-00-0527 14 23 Lung Cancer M 77  
222 47 YY-00-0534 14 24 Lung Cancer M 75  
227 52 YY-01-0029 14 26 Lung Cancer F 58 squamous
232 57 YY-01-0091 14 27 Lung Cancer M 64 squamous
237 62 YY-01-0135 14 28 Lung Cancer F 64 adenocarcinoma
242 67 YY-01-0142 14 29 Lung Cancer U U squamous
247 72 YY-01-0181 14 30 Lung Cancer U U squamous
252 2 YY-00-0012 15 1 Lymphoma M 59 IPOX: positive for CD19, CD20, CD22, CD10, lambda
257 7 YY-00-0017 15 2 Lymphoma M 89 IPOX: positive for T-marker (unspecfied), CD30
262 12 YY-00-0046 15 3 Lymphoma M 40 PTLD, EBV negatve, clonal by PCR, IPOX CD20 positive
267 17 YY-00-0126 15 4 Lymphoma F 74 Flow, positive for CD10, CD19, CD20, lambda
272 22 YY-00-0134 15 5 Lymphoma M 58 IPOX positive for CD19, CD20, FMC7, lambda, negative for CD5, CD23
277 27 YY-00-0297 15 7 Lymphoma M 69 spleen, flow negative for CD5 and CD10
282 32 YY-00-0302 15 8 Lymphoma F 20 Hodgkins Lymphoma, IPOX positive CD30, CD15, CD20 , status post treatment
287 37 YY-00-0513 15 9 Lymphoma M 59 IPOX positive CD5, CD20, CD23
292 42 YY-01-0056 15 10 Lymphoma F 21 HD, NS
297 47 YY-01-0123 15 11 Lymphoma U U SLL/CLL
178 3 YY-00-0073 15 14 Lung Cancer F 48  
183 8 YY-00-0081 15 15 Lung Cancer M 75  
188 13 YY-00-0141 15 16 Lung Cancer M 51  
193 18 YY-00-0150 15 17 Lung Cancer U U  
198 23 YY-00-0156 15 18 Lung Cancer M 64  
203 28 YY-00-0162 15 20 Lung Cancer M 47  
208 33 YY-00-0172 15 21 Lung Cancer M 62  
213 38 YY-00-0314 15 22 Lung Cancer U U  
218 43 YY-00-0529 15 23 Lung Cancer F 37  
223 48 YY-01-0025 15 24 Lung Cancer M 70 squamous
228 53 YY-01-0030 15 26 Lung Cancer M 71 squamous
233 58 YY-01-0092 15 27 Lung Cancer M 71 squamous
238 63 YY-01-0136 15 28 Lung Cancer U U squamous
243 68 YY-01-0175 15 29 Lung Cancer U U squamous
248 73 YY-01-0182 15 30 Lung Cancer U U poorly differentiated
253 3 YY-00-0013 16 1 Lymphoma F 79 IPOX: positive for CD19, CD20, lambda
258 8 YY-00-0018 16 2 Lymphoma M 89 IPOX: positive CD4, CD13, CD30, EMA, vimentin, negative for L-26, CD43
263 13 YY-00-0047 16 3 Lymphoma M 71  
268 18 YY-00-0127 16 4 Lymphoma F 81 IPOX positive CD20, CD10, negative CD3, cyclin D1
273 23 YY-00-0135 16 5 Lymphoma F 39 IPOX positive for CD20, CD30, negative for CD3, CD15, EMA
278 28 YY-00-0298 16 7 Lymphoma F U IPOX positive for CD20
283 33 YY-00-0303 16 8 Lymphoma F 59  
288 38 YY-01-0038 16 9 Lymphoma F 70 B-cell, CD20, CD79a, CD30 pos, S-100, LeuM1, CD15 neg
293 43 YY-01-0057 16 10 Lymphoma M 69 Large T cell, pos CD45RO, CD30, CD3, neg for CD20, EMA , CD45R
298 48 YY-01-0124 16 11 Lymphoma U U follicular
179 4 YY-00-0075 16 14 Lung Cancer F 75  
184 9 YY-00-0082 16 15 Lung Cancer F 64  
189 14 YY-00-0142 16 16 Lung Cancer F 73  
194 19 YY-00-0151 16 17 Lung Cancer F 40  
199 24 YY-00-0158 16 18 Lung Cancer F 76  
204 29 YY-00-0163 16 20 Lung Cancer M 75  
209 34 YY-00-0173 16 21 Lung Cancer M 46  
214 39 YY-00-0316 16 22 Lung Cancer F 72  
219 44 YY-00-0530 16 23 Lung Cancer M 56  
224 49 YY-01-0026 16 24 Lung Cancer M 68 squamous
229 54 YY-01-0032 16 26 Lung Cancer F 67 squamous
234 59 YY-01-0094 16 27 Lung Cancer M 74 adeno
239 64 YY-01-0137 16 28 Lung Cancer U U adenocarcinoma
244 69 YY-01-0176 16 29 Lung Cancer U U Bronchioloalveolar
249 74 YY-01-0215 16 30 Lung Cancer F 42 poorly Differentiated Ca
254 4 YY-00-0014 17 1 Lymphoma U 16 IPOX: positive for CD30, CD15 (focal), negative for CD20, EMA, UCHL1
259 9 YY-00-0020 17 2 Lymphoma M 24  
264 14 YY-00-0049 17 3 Lymphoma M 69 IPOX positive for CD30, CD45RO, CD3 9weak), negative for CD20, CD45R and EMA
269 19 YY-00-0128 17 4 Lymphoma F 34 Hodgkins Lymphoma, R-S cells IPOX positive for CD15, CD30, CD20(focal)
274 24 YY-00-0137 17 5 Lymphoma M 63 Flow positive for CD19, CD20/CD5 (coexpression) and CD23
279 29 YY-00-0299 17 7 Lymphoma M 74  
284 34 YY-00-0304 17 8 Lymphoma M 37 Hodgkins Lymphoma IPOX positive L-26, EMA, negative for LeuM1, CD30
289 39 YY-01-0039 17 9 Lymphoma M 39 spleen, flow CD2, CD3, CD56, CD16 pos, CD7 dim
294 44 YY-01-0058 17 10 Lymphoma U U HD, NS, RS cells CD30 pos
299 49 YY-01-0206 17 11 Lymphoma U U CD20+, bcl-2+, CD43+, CD5-, CF10-, CD23-, cyclin D1-
180 5 YY-00-0077 17 14 Lung Cancer M 78  
185 10 YY-00-0089 17 15 Lung Cancer U U  
190 15 YY-00-0144 17 16 Lung Cancer F 71  
195 20 YY-00-0152 17 17 Lung Cancer F 67  
200 25 YY-00-0159 17 18 Lung Cancer M 62  
205 30 YY-00-0165 17 20 Lung Cancer M 73  
210 35 YY-00-0190 17 21 Lung Cancer F 38  
215 40 YY-00-0320 17 22 Lung Cancer M 71  
220 45 YY-00-0531 17 23 Lung Cancer M 62  
225 50 YY-01-0027 17 24 Lung Cancer M 60 adeno, with papillary features, thyroglobulin negative
230 55 YY-01-0089 17 26 Lung Cancer F 60  
235 60 YY-01-0095 17 27 Lung Cancer F 43 squamous
240 65 YY-01-0138 17 28 Lung Cancer U U squamous
245 70 YY-01-0177 17 29 Lung Cancer U U poorly differentiated
250 75 YY-01-0216 17 30 Lung Cancer F 63 squamous, 10.5 cm
255 5 YY-00-0015 18 1 Lymphoma M 49  
260 10 YY-00-0021 18 2 Lymphoma M 99 B-cell phenotype by flow
265 15 YY-00-0050 18 3 Lymphoma M 67 IPOX positive for CD3, CD30, CD43, CD45RO, negative for CD20, CD45R, CD75 & Alk
270 20 YY-00-0129 18 4 Lymphoma M 75 IPOX positive for CD20, CD23, CD21, negative CD3, CD43
275 25 YY-00-0294 18 5 Lymphoma M 54  
280 30 YY-00-0300 18 7 Lymphoma M 51  
285 35 YY-00-0509 18 8 Lymphoma M 54  
290 40 YY-01-0040 18 9 Lymphoma F 68 spleen, flow CD19, CD20, Kappa, surface IgM pos, CD5 dim
295 45 YY-01-0060 18 10 Lymphoma M 6 flow CD45, CD19, CD20, CD22, Kappa
300 50 YY-01-0207 18 11 Lymphoma U U CLL/SCL CD20+, CD79a+, CD23+, CD5+, CD3-, CD10-, Cyclin D1-
376 1 YY-00-0362 19 14 Prostatic Adenocarcinoma M U  
381 6 YY-00-0370 19 15 Prostatic Adenocarcinoma M U  
386 11 YY-00-0378 19 16 Prostatic Adenocarcinoma M U  
391 16 YY-00-0386 19 17 Prostatic Adenocarcinoma M U  
396 21 YY-00-0394 19 18 Prostatic Adenocarcinoma M U  
401 26 YY-00-0408 19 20 Prostatic Adenocarcinoma M U  
406 31 YY-00-0416 19 21 Prostatic Adenocarcinoma M U  
411 36 YY-00-0427 19 22 Prostatic Adenocarcinoma M U  
416 41 YY-00-0438 19 23 Prostatic Adenocarcinoma M U  
421 46 YY-00-0445 19 24 Prostatic Adenocarcinoma M U  
426 51 YY-00-0452 19 26 Prostatic Adenocarcinoma M U  
431 56 YY-00-0459 19 27 Prostatic Adenocarcinoma M U  
436 61 YY-01-0099 19 28 Prostatic Adenocarcinoma M 71  
441 66 YY-01-0221 19 29 Prostatic Adenocarcinoma M U Gleason Grade 3+3=6/10, very limited tumor available
446 71   19 30 Prostatic Adenocarcinoma     No tissue
326 1 YY-00-0001 20 1 Ovarian Adenocarcinoma F U mucinous
331 6 YY-00-0009 20 2 Ovarian Adenocarcinoma F 59 serous papillary
336 11 YY-00-0114 20 3 Ovarian Adenocarcinoma F 49 endometroid
341 16 YY-00-0284 20 4 Ovarian Adenocarcinoma F 31 serous papillary
346 21 YY-00-0515 20 5 Ovarian Adenocarcinoma F 62 serous papillary
351 26 YY-00-0524 20 7 Ovarian Adenocarcinoma F 60 serous papillary
356 31 YY-01-0053 20 8 Ovarian Adenocarcinoma F 58 papillary serous
361 36 YY-01-0110 20 9 Ovarian Adenocarcinoma F U poorly differentiated with clear cell features
366 41 YY-01-0238 20 10 Ovarian Adenocarcinoma F 59 serous papillary
371 46 YY-01-0247 20 11 Ovarian Adenocarcinoma F 79 serous papillary
377 2 YY-00-0363 20 14 Prostatic Adenocarcinoma M U  
382 7 YY-00-0371 20 15 Prostatic Adenocarcinoma M U  
387 12 YY-00-0379 20 16 Prostatic Adenocarcinoma M U  
392 17 YY-00-0387 20 17 Prostatic Adenocarcinoma M U  
397 22 YY-00-0397 20 18 Prostatic Adenocarcinoma M U  
402 27 YY-00-0409 20 20 Prostatic Adenocarcinoma M U  
407 32 YY-00-0418 20 21 Prostatic Adenocarcinoma M U  
412 37 YY-00-0428 20 22 Prostatic Adenocarcinoma M U  
417 42 YY-00-0439 20 23 Prostatic Adenocarcinoma M U  
422 47 YY-00-0447 20 24 Prostatic Adenocarcinoma M U  
427 52 YY-00-0453 20 26 Prostatic Adenocarcinoma M U  
432 57 YY-00-0460 20 27 Prostatic Adenocarcinoma M U appears on TARP1, not on TARP2
437 62 YY-01-0191 20 28 Prostatic Adenocarcinoma M U  
442 67   20 29 Prostatic Adenocarcinoma     No tissue
447 72   20 30 Prostatic Adenocarcinoma     No tissue
327 2 YY-00-0002 21 1 Ovarian Adenocarcinoma F 54 serous papillary
332 7 YY-00-0105 21 2 Ovarian Adenocarcinoma F 69 serous papillary
337 12 YY-00-0117 21 3 Ovarian Adenocarcinoma F 47 endometroid
342 17 YY-00-0288 21 4 Ovarian Adenocarcinoma F U serous papillary
347 22 YY-00-0517 21 5 Ovarian Adenocarcinoma F 60 serous papillary
352 27 YY-01-0035 21 7 Ovarian Adenocarcinoma F 67 papillary serous
357 32 YY-01-0062 21 8 Ovarian Adenocarcinoma F 59 endometroid
362 37 YY-01-0111 21 9 Ovarian Adenocarcinoma F U papillary serous adenoca
367 42 YY-01-0239 21 10 Ovarian Adenocarcinoma F 64 serous papillary
372 47 YY-01-0248 21 11 Ovarian Adenocarcinoma F 72 serous papillary
378 3 YY-00-0364 21 14 Prostatic Adenocarcinoma M U  
383 8 YY-00-0372 21 15 Prostatic Adenocarcinoma M U  
388 13 YY-00-0381 21 16 Prostatic Adenocarcinoma M U  
393 18 YY-00-0389 21 17 Prostatic Adenocarcinoma M U  
398 23 YY-00-0400 21 18 Prostatic Adenocarcinoma M U  
403 28 YY-00-0410 21 20 Prostatic Adenocarcinoma M U  
408 33 YY-00-0422 21 21 Prostatic Adenocarcinoma M U  
413 38 YY-00-0430 21 22 Prostatic Adenocarcinoma M U  
418 43 YY-00-0440 21 23 Prostatic Adenocarcinoma M U  
423 48 YY-00-0448 21 24 Prostatic Adenocarcinoma M U  
428 53 YY-00-0454 21 26 Prostatic Adenocarcinoma M U  
433 58 YY-00-0461 21 27 Prostatic Adenocarcinoma M U appears on TARP1, not on TARP2
438 63 YY-01-0218 21 28 Prostatic Adenocarcinoma M U Gleason Grade 3+4=7/10, perineural invasion
443 68   21 29 Prostatic Adenocarcinoma     No tissue
448 73   21 30 Prostatic Adenocarcinoma     No tissue
328 3 YY-00-0005 22 1 Ovarian Adenocarcinoma F 43 serous papillary
333 8 YY-00-0106 22 2 Ovarian Adenocarcinoma F 56 serous papillary
338 13 YY-00-0120 22 3 Ovarian Adenocarcinoma F 23 mucinous
343 18 YY-00-0289 22 4 Ovarian Adenocarcinoma F U serous papillary
348 23 YY-00-0518 22 5 Ovarian Adenocarcinoma F 52 serous papillary
353 28 YY-01-0036 22 7 Ovarian Adenocarcinoma F 78 endometroid
358 33 YY-01-0063 22 8 Ovarian Adenocarcinoma F 46 clear cell Ca
363 38 YY-01-0112 22 9 Ovarian Adenocarcinoma F U papillary serous adenoca
368 43 YY-01-0240 22 10 Ovarian Adenocarcinoma F 76 serous papillary
373 48 YY-01-0249 22 11 Ovarian Adenocarcinoma F 58 clear cell
379 4 YY-00-0367 22 14 Prostatic Adenocarcinoma M U  
384 9 YY-00-0373 22 15 Prostatic Adenocarcinoma M U  
389 14 YY-00-0382 22 16 Prostatic Adenocarcinoma M U  
394 19 YY-00-0390 22 17 Prostatic Adenocarcinoma M U  
399 24 YY-00-0403 22 18 Prostatic Adenocarcinoma M U  
404 29 YY-00-0412 22 20 Prostatic Adenocarcinoma M U  
409 34 YY-00-0424 22 21 Prostatic Adenocarcinoma M U  
414 39 YY-00-0436 22 22 Prostatic Adenocarcinoma M U  
419 44 YY-00-0442 22 23 Prostatic Adenocarcinoma M U  
424 49 YY-00-0449 22 24 Prostatic Adenocarcinoma M U  
429 54 YY-00-0455 22 26 Prostatic Adenocarcinoma M U  
434 59 YY-01-0045 22 27 Prostatic Adenocarcinoma M 61  
439 64 YY-01-0219 22 28 Prostatic Adenocarcinoma M U Gleason Grade 3+3=6/10, very limited tumor available
444 69   22 29 Prostatic Adenocarcinoma     No tissue
449 74   22 30 Prostatic Adenocarcinoma     No tissue
329 4 YY-00-0007 23 1 Ovarian Adenocarcinoma F 74 serous papillary
334 9 YY-00-0109 23 2 Ovarian Adenocarcinoma F 50 clear cell Ca
339 14 YY-00-0121 23 3 Ovarian Adenocarcinoma F 69 serous papillary
344 19 YY-00-0290 23 4 Ovarian Adenocarcinoma F U clear cell Ca
349 24 YY-00-0519 23 5 Ovarian Adenocarcinoma F 72 serous papillary
354 29 YY-01-0037 23 7 Ovarian Adenocarcinoma F 47 papillary serous
359 34 YY-01-0100 23 8 Ovarian Adenocarcinoma F 67 papillary serous
364 39 YY-01-0213 23 9 Ovarian Adenocarcinoma F 47 Clear Cell Ca
369 44 YY-01-0242 23 10 Ovarian Adenocarcinoma F 43 clear cell
374 49 YY-01-0250 23 11 Ovarian Adenocarcinoma F U papillary serous
380 5 YY-00-0369 23 14 Prostatic Adenocarcinoma M U  
385 10 YY-00-0377 23 15 Prostatic Adenocarcinoma M U  
390 15 YY-00-0384 23 16 Prostatic Adenocarcinoma M U  
395 20 YY-00-0393 23 17 Prostatic Adenocarcinoma M U  
400 25 YY-00-0404 23 18 Prostatic Adenocarcinoma M U  
405 30 YY-00-0414 23 20 Prostatic Adenocarcinoma M U  
410 35 YY-00-0425 23 21 Prostatic Adenocarcinoma M U  
415 40 YY-00-0437 23 22 Prostatic Adenocarcinoma M U  
420 45 YY-00-0444 23 23 Prostatic Adenocarcinoma M U  
425 50 YY-00-0450 23 24 Prostatic Adenocarcinoma M U  
430 55 YY-00-0458 23 26 Prostatic Adenocarcinoma M U  
435 60 YY-01-0047 23 27 Prostatic Adenocarcinoma M 68  
440 65 YY-01-0220 23 28 Prostatic Adenocarcinoma M U Gleason Grade 3+3=6/10
445 70   23 29 Prostatic Adenocarcinoma     No tissue
450 75   23 30 Prostatic Adenocarcinoma     No tissue
330 5 YY-00-0008 24 1 Ovarian Adenocarcinoma F 69 serous papillary
335 10 YY-00-0110 24 2 Ovarian Adenocarcinoma F 25 mucinous cystadenoma, uncertain malignant potential
340 15 YY-00-0123 24 3 Ovarian Adenocarcinoma F 74 serous papillary
345 20 YY-00-0293 24 4 Ovarian Adenocarcinoma F 76 serous papillary
350 25 YY-00-0523 24 5 Ovarian Adenocarcinoma F 67 endometroid
355 30 YY-01-0051 24 7 Ovarian Adenocarcinoma F 73 papillary serous
360 35 YY-01-0109 24 8 Ovarian Adenocarcinoma F U clear cell Ca
365 40 YY-01-0214 24 9 Ovarian Adenocarcinoma F U Papillary Serous AdenoCa
370 45 YY-01-0245 24 10 Ovarian Adenocarcinoma F 69 serous papillary
375 50 YY-01-0251 24 11 Ovarian Adenocarcinoma F U papillary serous